Calliditas Therapeutics AB (publ) (CALT)
Upgrades & Downgrades
Latest CALT news
Calliditas' Kinpeygo Receives CHMP Backing For Kidney Disease
19 May 2022
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending conditional approval for Calliditas Therapeutics AB's (NASDAQ: CALT) K...
Calliditas Expects EMA's CHMP Opinion For Nefecon In Q2
22 March 2022
Calliditas Therapeutics AB (NASDAQ: CALT) says that the opinion of the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) can be expected in Q2 of 2022. In it...
5 Biotech Stocks For Your Late December 2021 Watchlist
16 December 2021
Should investors be treating these top biotech stocks as top picks in the stock market now?
Calliditas' (CALT) Tarpeyo Wins FDA Approval for Renal Disease
16 December 2021
Calliditas (CALT) obtains accelerated approval for Tarpeyo to reduce proteinuria in IgA nephropathy in the United States.
Calliditas Therapeutics: Q3 Earnings Insights
18 November 2021
Calliditas Therapeutics (NASDAQ:CALT) reported its Q3 earnings results on Thursday, November 18, 2021 at 01:00 AM. Here's what investors need to know about the announcement.
Calliditas announces acquisition of remaining Genkyotex minority shares
7 October 2021
STOCKHOLM, Oct. 7, 2021 /PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX) ("Calliditas") today announced that the company now controls 100% of the share capital of Ge...
Is a Surprise Coming for Calliditas (CALT) This Earnings Season?
10 August 2021
Calliditas (CALT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Calliditas Receives FDA Fast Track Designation for setanaxib in PBC
9 August 2021
STOCKHOLM, Aug. 9, 2021 /PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX) ("Calliditas") today announced that the U.S. Food and Drug Administration (FDA) has granted ...
Calliditas Therapeutics and STADA partner to register and commercialize specialty therapy for IgA Ne...
21 July 2021
STOCKHOLM and BAD VILBEL, Germany, July 21, 2021 /PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT), (Nasdaq Stockholm: CALTX) ("Calliditas") and STADA Arzneimittel AG ("STADA") announced today...